Acute administration of IL-6 improves indices of hepatic glucose and insulin homeostasis in lean and obese mice

Exercise Protects Against Olanzapine-Induced Hyperglycemia in Male C57BL/6J Mice

(2018) Laura N. Castellani et al.   Scientific Reports

Interleukin-6 increases the expression and activity of insulin-degrading enzyme

(2017) Mirian A. Kurauti et al.   Scientific Reports

A return to ad libitum feeding following caloric restriction promotes hepatic steatosis in hyperphagic OLETF rats

(2016) Melissa A. Linden et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Exercise-induced increase in IL-6 level enhances GLUT4 expression and insulin sensitivity in mouse skeletal muscle

(2016) Shin-ichi Ikeda et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Treatment with a novel agent combining docosahexaenoate and metformin increases protectin DX and IL-6 production in skeletal muscle and reduces insulin resistance in obese diabetic db/db mice

(2016) Patricia L. Mitchell et al.   DIABETES OBESITY & METABOLISM

The ever-expanding myokinome: discovery challenges and therapeutic implications

(2016) Martin Whitham et al.   NATURE REVIEWS DRUG DISCOVERY

Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice

(2015) M. Vida et al.   Disease Models & Mechanisms

Adipose Tissue Insulin Action and IL-6 Signaling after Exercise in Obese Mice

(2015) REBECCA E. K. MACPHERSON et al.   MEDICINE AND SCIENCE IN SPORTS AND EXERCISE

A subcutaneous adipose tissue–liver signalling axis controls hepatic gluconeogenesis

(2015) Shannon M. Reilly et al.   Nature Communications

From cytokine to myokine: the emerging role of interleukin-6 in metabolic regulation

(2014) Martin Pal et al.   IMMUNOLOGY AND CELL BIOLOGY

Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013

(2014) Marie Ng et al.   LANCET

Partial hepatic resistance to IL-6-induced inflammation develops in type 2 diabetic mice, while the anti-inflammatory effect of AMPK is maintained

(2014) Emmelie Cansby et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Protectin DX alleviates insulin resistance by activating a myokine-liver glucoregulatory axis

(2014) Phillip J White et al.   NATURE MEDICINE

Selective hepatic insulin resistance in a murine model heterozygous for a mitochondrial trifunctional protein defect

(2013) R. Scott Rector et al.   HEPATOLOGY

IL-6 is not essential for exercise-induced increases in glucose uptake

(2013) Hayley M. O'Neill et al.   JOURNAL OF APPLIED PHYSIOLOGY

PGC-1α overexpression results in increased hepatic fatty acid oxidation with reduced triacylglycerol accumulation and secretion

(2012) E. Matthew Morris et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Signal Transducer and Activator of Transcription 3 in Liver Diseases: A Novel Therapeutic Target

(2012) Hua Wang et al.   International Journal of Biological Sciences

A Single Bout of Exercise Increases the Expression of Glucose but not Fatty Acid Transporters in Skeletal Muscle of IL-6 KO Mice

(2012) B. Łukaszuk et al.   LIPIDS

NIH Image to ImageJ: 25 years of image analysis

(2012) Caroline A Schneider et al.   NATURE METHODS

Association between Serum Interleukin-6 Concentrations and Mortality in Older Adults: The Rancho Bernardo Study

(2012) Jeffrey K. Lee et al.   PLoS One

Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells

(2011) Helga Ellingsgaard et al.   NATURE MEDICINE

In humans IL-6 is released from the brain during and after exercise and paralleled by enhanced IL-6 mRNA expression in the hippocampus of mice

(2010) P. Rasmussen et al.   Acta Physiologica

Reversible Ponceau staining as a loading control alternative to actin in Western blots

(2010) Isabel Romero-Calvo et al.   ANALYTICAL BIOCHEMISTRY

IL-6 deficiency in mice neither impairs induction of metabolic genes in the liver nor affects blood glucose levels during fasting and moderately intense exercise

(2010) L. Fritsche et al.   DIABETOLOGIA

Direct medical cost of overweight and obesity in the USA: a quantitative systematic review

(2010) A. G. Tsai et al.   Obesity Reviews

STAT3 Targets the Regulatory Regions of Gluconeogenic Genesin Vivo

(2009) Preeti Ramadoss et al.   MOLECULAR ENDOCRINOLOGY

Obesity and overweight in Canada: an updated cost-of-illness study

(2009) A. H. Anis et al.   Obesity Reviews